| Token | #177 of SciMatic Articles (ERC-1155), fixed supply 1,000,000 |
|---|---|
| Contract | 0x0E596B4bb924937aA35D9b342A90347ed6F05eF8 |
| Mint transaction | 0xd85ee90f114cded93862ff8a8d19375c9707f78d13063a33b62c1c0886f14f8e · block 12096775 |
| Minted | 2026-10-01 17:07 UTC |
| Hash on chain | 0xc9444a1bd7362d3f5435725a0b50a7dca0bd89f1577ef90a32d20d917747b16c |
| SHA-256 of the record | 0xc9444a1bd7362d3f5435725a0b50a7dca0bd89f1577ef90a32d20d917747b16c |
| Article today | Matches the anchored record. |
| Holder | Wallet | Minted | Holds now |
|---|---|---|---|
| SciMatic (10%) | 0xc35709AB…277732 | 100,000 | 100,000 |
| Dr. Hayat Ullah | 0x15737B62…664aCA | 60,000 | 60,000 |
| Fahad Khan | 0x2A61357D…1C1882 | 60,000 | 60,000 |
| Imad Uddin | 0x455B3e56…4cE434 | 60,000 | 60,000 |
| Fazal Rahim | 0x6B431019…23ba89 | 60,000 | 60,000 |
| Muhammad Taha | 0xcbB611DF…1c00Be | 60,000 | 60,000 |
| Khalid Zaman | 0xB1e0e305…5B5800 | 60,000 | 60,000 |
| Aftab Ahmad Khan | 0x9751D320…56e0E4 | 60,000 | 60,000 |
| Fawad Ahmad | 0xE87De0bF…7cc5d5 | 60,000 | 60,000 |
| Zia Ur Rehman | 0xD5a1698a…55F925 | 60,000 | 60,000 |
| Fazal Suhrab Gul | 0x62B8FAF0…9a3A0F | 60,000 | 60,000 |
| Mehran | 0x00DA1320…691126 | 60,000 | 60,000 |
| Nisar Ahmad | 0x35F8C388…8e1Ca2 | 60,000 | 60,000 |
| Mushtaq Ahmad | 0x00424d3C…a04e1a | 60,000 | 60,000 |
| Muhammad Imran Fakhri | 0x763aad3e…11c0a0 | 60,000 | 60,000 |
| Khalid Mohammad Khan | 0xfce3D694…e347dD | 60,000 | 60,000 |
Canonical JSON (keys sorted, no spaces, UTF-8). Its SHA-256 is the hash on chain.
{"abstract":"Prostate cancer is perhaps the most dominant cancer in men. The increased resistance to therapeutic agents and deficiency of targeted therapy for prostate cancer cells offer motivation to find new scaffolds for the treatment. The current study investigates substituted biscoumarin analogs (1-19) anticancer activity in the prostate cancer (PC3) cell line and its antioxidant potential. Out of these nineteen analogs, the compounds 1, 8, 9, 10, 12, 14, 16, 18 and 19 showed good PC3 cell line inhibitory potential when compared with the standard doxorubicin. Compounds 1-19 were also checked for DPPH radical scavenging potential. Compounds 2, 5, and 17 showed good potential. All analogs were also evaluated for superoxide anion scavenging activity and found to be inactive. The docking analysis shows that the biscoumarin is an anti-cancer ligand and has the ability to inhibit the activity of the human histone acetyltransferase. Overall this study has contributed for anticancer and antioxidant agents.","abstract_source":"original","authors":["Dr. Hayat Ullah","Fahad Khan","Imad Uddin","Fazal Rahim","Muhammad Taha","Khalid Zaman","Aftab Ahmad Khan","Fawad Ahmad","Zia Ur Rehman","Fazal Suhrab Gul","Mehran","Nisar Ahmad","Mushtaq Ahmad","Muhammad Imran Fakhri","Khalid Mohammad Khan"],"date":"2020","doi":"10.5281/zenodo.3703324","id":177,"issue":1,"journal":{"issn":"2651-4338","name":"Journal of Ongoing Chemical Research"},"pdf_sha256":"3da4bb41d2f07a2821dda197e365e51a3173b4659833bdebe4bb4d1477ad1f42","schema":"scimatic-article/1","title":"Synthetic Biscoumarin Analogs: Their PC3 Cell Line and Antioxidant Inhibitory Potentials","volume":5}
1. The record, from the token's own metadata:
printf '%s' "$(curl -s https://scimatic.org/nft/articles/177.json | jq -r .canonical_record)" | sha256sum
2. The hash stored on chain (contentHash(177)):
curl -s https://rpc.scimatic.net -H 'content-type: application/json' \
-d '{"jsonrpc":"2.0","id":1,"method":"eth_call","params":[{"to":"0x0E596B4bb924937aA35D9b342A90347ed6F05eF8","data":"0xf3e0c29000000000000000000000000000000000000000000000000000000000000000b1"},"latest"]}'
The two must be equal (the second with a 0x in front).